A Common Diabetes Drug Could Be a Fountain of Youth For Our Brains

Scientists in China have found evidence in monkeys that metformin can reliably slow down the brain's aging process.

One of the world’s most commonly taken drugs could be even more beneficial than advertised. A new study this month shows that metformin may potentially slow aging in the body and brain of monkeys. While more research in humans will be needed to confirm these findings, the drug is both cheap and already widely available.

, a large group of researchers in China have taken an important step forward in addressing this data gap.), roughly equal to 13 years of human life. They regularly gave metformin to 12 older monkeys during that study period, and compared the health of these monkeys to two different control groups not given the drug: one group of 16 older monkeys and another group of 18 young to middle-aged monkeys.

“Our research pioneers the systemic reduction of multi-dimensional biological age in primates through metformin, paving the way for advancing pharmaceutical strategies against human aging,” the researchers wrote.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Gizmodo /  🏆 556. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

New diabetes, weight loss medications cut diabetes risk by 94% in adults, Lilly saysA three-year study of tirzepatide (Mounjaro/Zepbound) found that when adults who had prediabetes and obesity or overweight used it weekly, it lowered their risk of progression to diabetes by 94%
Read more »

Type 2 Diabetes Drug Linked to 35% Lower Dementia Risk in PatientsThe Best in Science News and Amazing Breakthroughs
Read more »

Eli Lilly weight loss drug reduces diabetes riskPolitical News and Conservative Analysis About Congress, the President, and the Federal Government
Read more »

Weight Loss Drug Zepbound Significantly Cuts Diabetes RiskThe weight loss and diabetes drug tirzepatide, sold under the brand name Zepbound, was highly effective at reducing the risk of progressing from prediabetes to the more serious condition of type 2 diabetes, according to an early look at study results released Tuesday by drugmaker Eli Lilly.
Read more »

Common Blood Pressure Drug Extends Lifespan And Slows Aging in AnimalsThe Best in Science News and Amazing Breakthroughs
Read more »

Weight Loss Drug Reduces Diabetes Risk by 94 Percent in Clinical TrialThe Best in Science News and Amazing Breakthroughs
Read more »